TAVI Hotline: new devices, new approaches

Watch later Remove
Related Publication
Interventions for Valvular Disease
Hotline / Late-Breaking Trials
Theatre Havane

Anchorperson: Kentaro Hayashida

Spokesperson: Tiffany Patterson

Discussants: Philippe Genereux, Howard Herrmann, Radoslaw Parma, Sondos Samargandy

Introduction

Kentaro Hayashida

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Danny Dvir

Discussion and audience interaction
Upper extremity versus lower extremity for accessory access sites during TAVI

Geert Versteeg

Discussion and audience interaction
DurAVR biomimetic transcatheter heart valve: early feasibility and first-in-human trial update

Christopher Meduri

Discussion and audience interaction
One-year efficacy and safety of the dry-pericardium aortic valve: A first-in-human feasibility study

Kasparas Briedis

Discussion and audience interaction
Using temporary permanent pacemaker as a one-month bridge after TAVI

Guangyuan Song

Discussion and audience interaction
Clinical evaluation of the Hydra self-expanding THV: 30 days results from the GENESIS-II study

Nagendra Boopathy Senguttuvan

Discussion and audience interaction
Conclusion

Tiffany Patterson

Suggested videos

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options
Watch later Remove
EAPCI Fellowship Grants Award Ceremony
Watch later Remove
PASCAL Precision system simulation showcase: grasp the difference!
Watch later Remove
Restoring vessel physiology drives outcomes - The Bioadaptor experience
Watch later Remove
Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems
Watch later Remove
PCR Round Table - How will the SMART trial results impact our practice and decision making in TAVI
Watch later Remove